Related Experiment Video

Updated: May 1, 2026

Zebrafish Larvae as a Model to Evaluate Potential Radiosensitizers or Protectors
04:53

Zebrafish Larvae as a Model to Evaluate Potential Radiosensitizers or Protectors

Published on: August 25, 2022

1.9K

[Carcinogenicity of antineoplastic drugs: classification, protection and prevention, use and evidence]

Pietro Apostoli, Simona Catalani, Roberto Bergonzi

    Giornale Italiano Di Medicina Del Lavoro Ed Ergonomia
    |March 27, 2014
    PubMed

    Insights

    Occupational exposure to antineoplastic drugs poses risks for healthcare workers and the general population. This review analyzes exposure, safety measures, and environmental risks associated with these potent medications.

    Area of Science:

    • Oncology
    • Occupational Health
    • Environmental Science

    Context:

    • Antineoplastic agents, used in cancer treatment, carry risks like mutagenicity and carcinogenicity.
    • Occupational exposure in healthcare settings differs significantly from patient exposure in terms of dose and duration.
    • Secondary malignant neoplasms are a known risk associated with specific cancer therapies.

    Purpose:

    • To review and update classifications of antineoplastic drug exposure.
    • To analyze current occupational exposure conditions and technical advancements for risk reduction.
    • To evaluate epidemiological data, exposure measurements, and environmental dispersion risks.

    Summary:

    • This review examines the occupational health risks of antineoplastic drugs for healthcare workers.
    • It assesses current safety protocols, technological improvements, and available epidemiological data.
    • The study also highlights the environmental dispersion of these agents as a public health concern.

    Impact:

    • Provides updated information on managing occupational risks associated with antineoplastic drugs.
    • Informs healthcare policies and practices to enhance worker safety.
    • Raises awareness about the broader environmental implications of antineoplastic drug use.

    More Related Videos

    Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo09:19

    Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

    Published on: February 6, 2015

    8.3K
    Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA04:12

    Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate DMBA-TPA

    Published on: December 19, 2019

    14.4K

    Related Concept Videos

    Mutagenicity and Carcinogenicity01:25

    Mutagenicity and Carcinogenicity

    Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
    2.0K
    Cancer Survival Analysis01:21

    Cancer Survival Analysis

    Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
    863
    Hazard Ratio01:12

    Hazard Ratio

    The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
    For example, in a clinical trial...
    756
    Cancer Prevention02:59

    Cancer Prevention

    Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
    Some...
    6.5K
    Cancer Prevention02:59

    Cancer Prevention

    2.6K
    Cancer02:18

    Cancer

    Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
    51.7K